Nemolizumab Therapeutic Cheat Sheet
Atopic dermatitis and prurigo nodularis are chronic, life-altering diseases with a common feature of debilitating pruritus that significantly impacts our patients’ qualities of life. For those with resistant and extensive disease, dermatologists now have nemolizumab in our armamentarium, the first FDA approved IL-31 inhibitor. We continue our series, Therapeutic Cheat Sheet, with a closer look a …
Atopic dermatitis and prurigo nodularis are chronic, life-altering diseases with a common feature of debilitating pruritus that significantly impacts our patients’ qualities of life. For those with resistant and extensive disease, dermatologists now have nemolizumab in our armamentarium, the first FDA approved IL-31 inhibitor. We continue our series, Therapeutic Cheat Sheet, with a closer look a … 
Pigmentary distress impacts people of all skin types, according to Dr. Gilly Munavalli, associate clinical professor of dermatology at Wake Forest University School of Medicine. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Munavalli shares how to use lasers and energy-based devices to treat pigmentary disorders. Find out what Dr. Munaval … 
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patient with vitiligo, is thought to be decreased. This report presents a case of melanoma developing on a non-sun-exposed site in a patient with skin of color and untreated vitiligo. It emphasizes the need … 
Delivering effective dermatologic care for patients with skin of color requires a deep understanding of their unique needs. In her presentation at the Skin of Color Update, Dr. Amy McMichael, professor in the Department of Dermatology at Wake Forest School of Medicine, shared practical insights on managing non-scarring alopecia, emphasizing the importance of considering both biological and cultura … 
Even routine medical dermatology procedures can induce pigmentary alterations in darker skin tones, notes Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Alexis outlines how skin co … 